Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
3. Titan Medical expands offering to $8m
Titan Medical shifted the size of its upcoming offering, which it previously expected to bring in $6 million (C$8 million) raising the amount of shares offered to put it in the range of $7 to $8 million (C$10-11 million) to support developing its sport robot-assisted surgery platform.
Canada-based Titan said it would put up 8.9-million-shares at about 65¢ per share, but has bumped its offering to a minimum of 11.1 million units and a max of 12.2 million. Read more
2. TransEnterix finalizes response to FDA over 510(k) for SurgiBot
TransEnterix said it finalized its response to the FDA in relation to the 510(k) application for its SurgiBot system.
Research Triangle Park, N.C.-based TransEnterix says the SurgiBot is the 1st patient-side robotically enhanced laparoscopy platform, designed to be wheeled to a patient’s bedside and operate through a single port. Read more
1. Stryker buys Synergetics neuro assets
Stryker said it agreed to acquire the entirety of Synergetics neuro portfolio for an undisclosed amount.
The buy puts Synergetics Malis generator, Malis disposable forceps as well as Stryker’s existing Sonopet tips and RF generator into Stryker’s portfolio, according to the Kalamazoo, Mich.-based company. Read more